Published online before print
April 22, 2009, 10.1183/09031936.00005309
Eur Respir J 2009; 34:1118-1126
Copyright ©ERS Journals Ltd 2009
Utility of quantitative T-cell responses versus unstimulated interferon- for the diagnosis of pleural tuberculosis
K. Dheda1,2,3,
R. N. van Zyl-Smit1,
L. A. Sechi4,
M. Badri1,
R. Meldau1,
S. Meldau1,
G. Symons1,
P. L. Semple1,
A. Maredza1,
R. Dawson1,
H. Wainwright5,
A. Whitelaw6,
Y. Vallie1,
P. Raubenheimer1,
E. D. Bateman1 and
A. Zumla3
1 Lung Infection and Immunity Unit and Centre for Tuberculosis Research and Innovation, University of Cape Town Lung Institute and Division of Pulmonology, Dept of Medicine, University of Cape Town, 2 Institute of Infectious Disease and Molecular Medicine, University of Cape Town 5 National Health Laboratory Service, Division of Anatomical Pathology, and 6 National Health Laboratory Service, Division of Medical Microbiology, Dept of Clinical Laboratory Sciences, University of Cape Town, Cape Town, South Africa. 3 Centre for Infectious Disease and International Health, Dept of Infection, University College Medical School, London, UK. 4 Dept of Biomedical Sciences, University of Sassari, Sassari, Italy.
CORRESPONDENCE: K. Dheda, Lung Infection and Immunity Unit, Division of Pulmonology, Dept of Medicine, University of Cape Town, J flr, Old Main Bldg, Groote Schuur Hospital, Observatory, Cape Town, 7925, South Africa. E-mail: keertan.dheda{at}uct.ac.za
Keywords: Diagnosis, diagnostic accuracy, human, interferon- , pleural effusion, tuberculosis
Received: January 13, 2009
Accepted April 7, 2009
The clinical utility of antigen-specific interferon (IFN)- release assays (IGRAs) using pleural mononuclear cells, for the diagnosis of tuberculosis (TB), requires clarification.
We compared the diagnostic utility of unstimulated pleural IFN- levels with several pleural antigen-specific T-cell IGRAs (early secretory antigenic target-6 and culture filtrate protein-10 (T-SPOT.®TB, QuantiFERON®-TB Gold In-tube), purified protein derivative (PPD) and heparin-binding haemagglutinin (HBHA)) in 78 South African TB suspects. Test results were compared against a clinical score and a reference standard.
Out of 74 evaluable subjects 48, seven and 19 had definite, probable and no TB, respectively. 11 (15%) out of 74 pleural samples (nine (19%) out of 48 of the definite TB cases) had total cell counts that were inadequate for T-cell processing. In the remaining 63 samples, the sensitivity, specificity, positive predictive value and negative predictive value of different diagnostic methods were as follows. Maximal bioclinical score: 54, 89, 92 and 43%, respectively; T-SPOT.®TB: 86, 60, 84 and 64%, respectively; QuantiFERON®-TB Gold In-tube: 57, 80, 87 and 44%, respectively; HBHA-specific IGRA: 59, 31, 64 and 27%, respectively; PPD-specific IGRA: 81, 40, 76 and 46%, respectively; and pleural fluid unstimulated IFN- : 97, 100, 100 and 94%, respectively.
Unstimulated IFN- was the most accurate test for distinguishing TB from non-TB effusions in a high-burden setting. The antigen-specific T-cell IGRAs were limited by suboptimal accuracy and the inability to isolate sufficient mononuclear cells to perform the assay.
Copyright © 2009 by the European Respiratory Society.
|